Filing Flows

Filing Flows › Adaptive Biotechnologies (ADPT) › Next earnings date

Adaptive Biotechnologies (ADPT) earnings: beat the estimate

Adaptive Biotechnologies (ADPT) reported on Nov 4, 2026 and beat the EPS estimate: $0.02 against −$0.10 (+120.3%). Revenue was $83.9M for Q3 2026, -11% year over year. It beat the EPS estimate in 80% of the quarters on record.

Last result+120.3% vs estimate
Beat rate80%

The last report

Adaptive Biotechnologies reported revenue of $83.9M for the third quarter 2026 (-11% Y/Y), net earnings $2.8M. How it makes money → · Every quarter →

Adaptive Biotechnologies: EPS against the estimate, last 5 reportsAdaptive Biotechnologies: EPS against the estimate, last 5 reportsEstimateReported−$0.14$0.06Nov 25−$0.18−$0.09Feb 26−$0.16−$0.13May 26−$0.13−$0.25Jul 26−$0.10$0.02Nov 26
Latest (Nov 26): Estimate −$0.10, Reported $0.02.

Adaptive Biotechnologies' latest quarter

Adaptive Biotechnologies, Q3 2026: revenue $83.9M (-11% year over year), operating margin -0.5%, net earnings $2.8M, operating cash flow $9.6M. The chart follows the revenue to costs, profit and cash.

Questions

Did Adaptive Biotechnologies beat earnings?

Adaptive Biotechnologies (ADPT) reported on Nov 4, 2026 and beat the EPS estimate: $0.02 against −$0.10 (+120.3%).

When does ADPT report earnings?

The next date is not set yet.

Does Adaptive Biotechnologies usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.